| Literature DB >> 17906316 |
S Narasimha Rao1, Niteen S Wairagkar, V Murali Mohan, Mukesh Khetan, Suresh Somarathi.
Abstract
Clinical data of 104 hospitalized children during the 2003 epidemic of encephalitis in Andhra Pradesh state was retrospectively analysed to know the clinical profile and risk factors associated with mortality. Fever was the first symptom associated with altered sensorium, seizures, diarrhoea and vomiting. Evolution of illness was very rapid with high fatality (47%). Majority of deaths occurred within the first 24 h of illness due to brainstem involvement. On multiple logistic regression analysis, high-grade fever, absent oculocephalic reflex and Glasgow coma score <7 were found to be significantly contributing to the mortality. Evidence of Chandipura virus was detected in these cases as the etiological agent.Entities:
Mesh:
Year: 2007 PMID: 17906316 PMCID: PMC7107257 DOI: 10.1093/tropej/fmm078
Source DB: PubMed Journal: J Trop Pediatr ISSN: 0142-6338 Impact factor: 1.165
Hematological and biochemical profile
| Parameter | Total tested | Mean (±2SD) | Reference range |
|---|---|---|---|
| Hemoglobin | 83 | 11.09 (8.76–13.42) | 11.5–15.5 gm/dl |
| Neutrophils | 83 | 59.88 (50.79–68.97) | 54–62% |
| Lymphocytes | 83 | 32.01 (22.71–41.32) | 25–33% |
| Total leukocyte count (TLC) | 83 | 8200 (3436–12963) | 4500–11000 Cells/cumn |
| Platelet count | 83 | 2.36 (1.37–3.36) | 1.5–4 lakhs/cumm |
| Serum sodium | 83 | 136.06 (127.36–144.76) | 138–145 mmol/l |
| Serum potassium | 83 | 4.14 (2.96–5.32) | 3.5–5.0 mmol/l |
| Blood urea | 83 | 18.58 (9.04–28.12) | 7–18 mg/dl |
| Serum Creatinine | 84 | 0.89 (0.57–1.21) | 0.5–1 mg/dl |
| Random blood sugar (RBS) | 84 | 102.29 (62.61–141.96) | 60–100 mg/dl |
| Total serum bilirubin (TSB) | 48 | 0.98 (0.75–1.21) | 0.2–1 mg/dl |
| SGPT | 48 | 22.40 (0–45.66) | 5–45 U/l |
| Alkaline phosphatase | 47 | 279.23 (53.27–505.20) | 145–420 U/l |
| Serum Ammonia | 47 | 77.36 (41.96–112.76) | 48–195 Microgram N/dl |
| Cerebrospinal fluid protein | 36 | 30.56 (12.4–48.71) | 15–45 mg/dl |
| Cerebrospinal fluid cell count | 36 | 2.39 (0− 6.28) | 0–5 cells/cumm |
Details of CHP viral studies
| PT no | Age/sex | IgM | POD | IgG | NT | Isolation | PCR | |||
|---|---|---|---|---|---|---|---|---|---|---|
| TS | BLD CLOT | TS | SR | CSF | ||||||
| 1 | 5/M | −ve | 1 | −ve | <10 | V/R | +ve | |||
| 4 | 4/F | −ve | 0 | −ve | <10 | +ve (PB) | ||||
| 5 | 4/F | −ve | 2 | −ve (SR/CSF) | <10 | +ve (V/R/M) | −ve (PB) | +ve | −ve | −ve |
| 7** | 6/F | −ve | 1 | −ve (SR/CSF) | 5 | −ve (V/R) | −ve (PB) | +ve | −ve | |
| 8 | 2.5/F | −ve | 2 | −ve | <10 | −ve (V/R/M) | +ve (PB) | −ve | −ve | −ve |
| 9 | 9/F | +ve | 8 | −ve | 270 | |||||
| 10 | 11/F | +ve | 7 | −ve | <10 | |||||
| 11 | 4/M | +ve | 7 | +ve | >270 | |||||
| 12 | 4/F | +ve | 14 | +ve | >270 | |||||
| 13 | 8/M | +ve | 0 | +ve | <10 | |||||
| 14 | 9/M | −ve | 1 | −ve | <10 | +ve (M) | +ve | |||
| 15 | 11/F | +ve | 12 | +ve | >270 | |||||
| 16 | 4/M | +ve | 10 | +ve | 270 | |||||
| 17 | 9/M | +ve | 7 | −ve | 90 | |||||
| 18 | 5/F | +ve | 6 | −ve | 10 | |||||
| 19 | 0.75/M | +ve | 6 | +ve | >270 | |||||
| 20 | 3/F | +ve | 5 | +ve (SR/CSF) | 270 | −ve (V/R/M) | −ve | −ve | ||
| 23 | 4/M | +ve | 7 | +ve (SR/CSF) | 90 | −ve (V/R/M) | −ve (PB) | −ve | −ve | |
| 24 | 5/M | +ve | 4 | −ve | <10 | +ve | ||||
| 25 | 4/F | +ve | 8 | +ve | >270 | |||||
| 32 | 8/F | −ve | 0 | −ve | 5 | −ve(V/R) | ND | +ve | NA | |
POD: Post Admission Day; PB: Peripheral blood Co-cultures; NT: Neutrilization test; ND: Not done; TS: Tissue culture; NA: Not available; BLD: Blood clot; V/R: Vero/RD; SR: Serum; V/R/M: Vero/RD/MDCK; CSF: Cerebrospinal fluid.
Comparing the clinical profile of CHP +ve cases (Group A) and others (Group B)
| Clinical feature | Group A (21) CHP | Group B (83) |
| Chi-square | 95% CI | OR |
|---|---|---|---|---|---|---|
| Age | ||||||
| ≤5 years | 10 (47.6%) | 51 (61.4%) | ||||
| > 5 years | 11 (52.4%) | 32 (38.6%) | 0.250 | 1.321 | 0.669–4.596 | 1.753 |
| Sex | ||||||
| Male | 09 (42.9%) | 50 (60.2%) | 0.151 | 2.063 | 0.188–1.305 | 0.495 |
| Female | 12 (57.1%) | 33 (39.8%) | ||||
| Nutrition | ||||||
| Normal | 09 (42.9%) | 34 (41%) | ||||
| Malnutrition (<3 centile, NCHS) | 12 (57.1%) | 49 (59%) | 0.875 | 0.025 | 0.410–2.848 | 1.081 |
| Fever grade | ||||||
| High grade | 09 (42.9%) | 34 (41%) | 0.875 | 0.025 | 0.351–2.437 | 0.925 |
| Low or mod. Grade | 12 (57.1%) | 49 (59%) | ||||
| Fever (duration) | ||||||
| ≤3 days | 17 (81%) | 73 (88%) | 0.401 | 0.705 | 0.480–6.141 | 1.718 |
| >3 days | 04 (19%) | 10 (12%) | ||||
| Seizure (type) | ||||||
| GTCS | 20 (95.2%) | 60 (72.3%) | 0.052 | 3.764 | 0.972 – 60.459 | 7.667 |
| Focal | 01 (4.8%) | 23 (27.7%) | ||||
| Altered sensorium (duration) | ||||||
| ≤1 day | 15 (71.4%) | 71 (85.5%) | 0.127 | 2.333 | 0.767–7.306 | 2.367 |
| >1 day | 06 (28.6%) | 12 (14.5%) | ||||
| GIT symptoms | ||||||
| Absent | 09 (42.9%) | 27 (32.5%) | 0.374 | 0.790 | 0.242–1.711 | 0.643 |
| Present | 12 (57.1%) | 56 (67.5%) | ||||
| Skin rash | ||||||
| Absent | 19 (90.5%) | 72 (86.7%) | 0.644 | 0.213 | 0.141–3.376 | 0.689 |
| Present | 2 (9.5%) | 11 (13.3%) | ||||
| Bleeding tendencies | ||||||
| Absent | 20(95.2%) | 80 (96.4%) | 1.000 | 0.000 | 0.132–13.508 | 1.333 |
| Present | 01 (4.8%) | 03 (3.6%) | ||||
| Shock | ||||||
| Absent | 20 (95.2%) | 81 (97.6%) | ||||
| Present | 01 (4.8%) | 02 (2.4%) | 0.565 | 0.331 | 0.175–23.463 | 2.025 |
| Pupils | ||||||
| Normal | 12 (57.1%) | 47 (56.6%) | 0.966 | 0.002 | 0.388–2.686 | 1.021 |
| Abnormal | 09 (42.9%) | 36 (43.4%) | ||||
| Occulo cephalic reflex | ||||||
| Present | 13 (61.9%) | 41 (49.4%) | 0.305 | 1.050 | 0.625–4.436 | 1.665 |
| Absent | 08 (38.1%) | 42 (50.6%) | ||||
| Glasgow coma scale | ||||||
| ≤7 | 14 (66.7%) | 54 (65.1%) | 0.890 | 0.019 | 0.338–2.265 | 0.931 |
| > 7 | 07 (33.3%) | 29 (34.9%) | ||||
| Out come | ||||||
| Death | 10 (47.6%) | 39 (47%) | 0.959 | 0.003 | 0.374–2.543 | 0.975 |
| Recovery | 11 (52.4%) | 44 (53%) |
Bivariate analysis of clinical profile
| Variable | Death/Total (%) | OR | 95% Cl |
|
|---|---|---|---|---|
| Fever grade | ||||
| Low to mod | 21/61 (34.4) | 1 | 1.566–8.071 | 0.002 |
| High | 28/43 (65.1) | 3.555 | ||
| Fever days | ||||
| >3 | 3/14 (21.4) | 1 | 1.002–14.66 | 0.05 |
| ≤3 | 46/90 (51.1) | 3.833 | ||
| Seizure (type) | ||||
| Focal | 14/24 (58.3) | 1 | 0.221–1.40 | 0.212 |
| GTCS | 35/80 (43.7) | 0.556 | ||
| Altered Sensorium (days) | ||||
| ≤1 | 46/86 (53.5) | 1 | 0.047–0.645 | 0.009 |
| >1 | 3/18 (16.7) | 0.174 | ||
| Oculocephalic Reflex | ||||
| Absent | 37/50 (74.0) | 1 | 0.041–0.247 | <0.001 |
| Present | 12/54 (22.2) | 0.10 | ||
| GIT symptoms | ||||
| Absent | 12/36 (33.3) | 1 | 1.029–5.536 | 0.043 |
| Present | 37/68 (54.4) | 2.387 | ||
| Skin rash | ||||
| Absent | 46/91 (50.5) | 1 | 0.076–1.137 | 0.076 |
| Present | 3/13 (23.1) | 0.293 | ||
| Bleeding tendencies | ||||
| Absent | 45/100 | 1 | 0–1.610 | 0.686 |
| Present | 4/4 (100) | 1639.89 | ||
| Pupils | ||||
| Normal | 17/59 (28.8) | 1 | 2.583–14.316 | <0.001 |
| Abnormal | 32/45 (71.1) | 6.081 | ||
| Shock | ||||
| Absent | 45/101 (45.5) | 1 | 0–1.710 | 0.727 |
| Present | 3/3 (100) | 1604.244 | ||
| Glasgow coma Score | ||||
| ≤7 | 44/68 (64.7) | 1 | 0.030–0.256 | <0.001 |
| >7 | 5/36 (31.9) | 0.088 | ||
| Vomiting | ||||
| Absent | 15/42 (35.7) | 1 | 0.977–4.890 | 0.057 |
| Present | 34/62 (54.8) | 2.186 | ||
| Diarrohea | ||||
| Absent | 27/65 (40.9) | 1 | 0.884–4.463 | 0.097 |
| Present | 22/38 (57.9) | 1.986 | ||
| Malnutrition | ||||
| Absent | 19/43 (44.2) | 1 | 0.558–2.677 | 0.616 |
| Present | 30/61 (49.2) | 1.222 | ||
| Respiration | ||||
| Regular | 36/88 (40.9) | 1 | 1.663–23.555 | 0.007 |
| Irregular | 13/16 (81.3) | 6.259 |